follow rmed result updat revenue/lp
estim report exhibit vs prior
compar consensu
vascular sale estim prior dermatolog
estim prior model gross margin prior
compar consensu rel valuat base pt remain
updat estim updat revenue/lp estim
report exhibit vs prior
compar adj consensu
vascular sale estim remain unchang
unit share obl set dermatolog estim
prior model gross margin unchang compar
consensu
thesi invest thesi ra medic busi model sole
predic peripher vascular cathet sale dabra laser
consol given away clinic practic meet cathet volum
requir ra medic strategi provid versatil atherectomi
tool abl deal type plaqu doesnt produc downstream
debri especi effect deal fibrou cap
guidewir cross requir photo-abl tool
tip cathet cost effici manner cathet asp
versu estim industri asp water base
carrier design dabra cathet allow low cost good
dispos cathet laser consol due energi effici
term consol consol portabl low power requir well
low cathet asp reson especi well profit orient
offic base set today compris estim us
atherectomi case load link base manag commentari rmed
increas dabra sale forc pace
place given anticip attrit sell effort focu
initi high-volum outpati base catheter lab
secondari emphasi hospit base center express earli
interest confer call commentari posit regard grow
bodi clinic feedback regard efficaci deliver safeti
dabra report payer pushback dabra serv sole
de-bulk tool atherectomi case dabra current label
us importantli compani embark new patient registri
bolster clinic evid base support us atherectomi
label rmed ce mark label atherectomi con pg
tr target
valuat risk pt arriv appli ev/sal multipl
revenu estim exhibit steep discount forward ev/sal mean/
median multipl enjoy fast grow smid med-tech peer exhibit
clinic evid develop complet resolut reimburs uncertainti surround lack
us atherectomi label solid commerci execut appear consider room
valu creation risk includ commerci execut competit price concess unforeseen
efficacy/safety/eas use issu dabra may aris littl adjud data
compil payer/competitor push-back dabra label current treatment
chronic total occlus atherectomi
page
page
strh estimatesconsensusstrh vs consensu cc est us vascular statementstrh estimatesconsensusstrh vs consensu cc incom estimatesconsensusstrh vs consensusmargin ra medic system inc
page
strh estimatesstrhconsensusstrh vs consensu cc est us vascular statementstrh estimatesstrhconsensusstrh vs consensu cc incom estimatesstrhconsensusstrh vs consensusmargin ebitda margin excl ra medic system inc
note entellu medic multipl calcul use transact valu respect
divid sale acquir buy entellu medic mdwd futur sale strh
estim other consensu
page
ev sale valuationra medic revenu ev/revenu enterpris valu debt equiti share valu per ofmarketrevenuerevenu cap system vascular medic hldg diabet targetenterpris valu ra medic system inc
page
except per share dermatolog total gross research total oper oper incom loss interest incom expens net interest pre-tax incom tax tax incom ep adjust ebitda incl adjust ebitda excl margin analysi sale gross margin margin margin oper ebitda margin incl ebitda margin excl profit expens growth analysi yr/yr total revenu oper incom ebitda excl ra medic system inc
rmed commerci stage medic devic compani design develop manufactur
excim laser use treat cardiovascular diseas lower extrem peripher arteri
diseas dermatolog condit psoriasi vitiligo atop dermat
invest thesi ra medic busi model sole predic peripher vascular
cathet sale dabra laser consol given away clinic practic meet cathet
volum requir ra medic strategi provid versatil atherectomi tool abl deal
type plaqu doesnt produc downstream debri especi
effect deal fibrou cap guidewir cross requir photo-
abl tool tip cathet cost effici manner cathet asp
versu estim industri asp water base carrier design dabra
cathet allow low cost good dispos cathet laser consol due
energi effici term consol consol portabl low power requir well
low cathet asp reson especi well profit orient offic base set
today compris estim us atherectomi case load link base
manag commentari rmed increas dabra sale forc pace
place given anticip attrit sell effort focu initi
high-volum outpati base catheter lab secondari emphasi hospit base
center express earli interest confer call commentari posit regard
grow bodi clinic feedback regard efficaci deliver safeti dabra
report payer pushback dabra serv sole de-bulk tool atherectomi case
dabra current label us importantli compani embark new
patient registri bolster clinic evid base support us atherectomi label
rmed ce mark label atherectomi
valuat risk
pt arriv appli ev/sal multipl revenu estim
steep discount forward ev/sal mean/median multipl
enjoy fast grow smid med-tech peer clinic evid develop complet
resolut reimburs uncertainti surround lack us atherectomi label solid
commerci execut appear consider room valu creation risk includ
commerci execut competit price concess unforeseen efficacy/safety/eas use issu
dabra may aris littl adjud data compil payer/competitor
push-back dabra label current treatment chronic total occlus atherectomi
compani mention note
page
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
